USE OF TRANEXAMIC ACID IN MEGALIPOSUCTION
Abstract
.
Downloads
References
Lawson JH, Murphy MP. Challenges for providing effective hemostasis in surgery and trauma. Sem Hematol 2004;41:55–64.
Henry DA, Carless PA, Moxey AJ, O'Connell D, McClelland B, Henderson KM, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;4:CD001886.
Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme controlling medicines: introduction. Semin Thromb Hemostasis 1997;23:493–501.
Sood J, Jayaraman L, Sethi N. Liposuction: anaesthesia challenges. Indian J Anaesth 2011;55(3):220-7.
Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al. (CRASH-2 trial collaborators). Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage(CRASH-2): a randomized, placebo-controlled trial. Lancet 2010;376(9734):23-32.
Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 2010;468(7):1905-11.